Canada markets closed

Pharmadrug Inc. (G11.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.01100.0000 (0.00%)
At close: 08:18AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 1.91M
Enterprise Value 2.90M
Trailing P/E 0.56
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.17
Price/Book (mrq)0.39
Enterprise Value/Revenue 10.90
Enterprise Value/EBITDA -0.71

Trading Information

Stock Price History

Beta (5Y Monthly) 2.91
52-Week Change 3214.38%
S&P500 52-Week Change 326.27%
52 Week High 30.0805
52 Week Low 30.0035
50-Day Moving Average 30.0192
200-Day Moving Average 30.0195

Share Statistics

Avg Vol (3 month) 395
Avg Vol (10 day) 3227
Shares Outstanding 593.96M
Implied Shares Outstanding 6173.78M
Float 850.77M
% Held by Insiders 10.88%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3Oct 24, 2023

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)37,892.73%

Management Effectiveness

Return on Assets (ttm)-4.89%
Return on Equity (ttm)16.47%

Income Statement

Revenue (ttm)-2.53k
Revenue Per Share (ttm)-0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA 32.65k
Net Income Avi to Common (ttm)1.45M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)188.42k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.6M
Total Debt/Equity (mrq)19.45%
Current Ratio (mrq)0.44
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)2.21M
Levered Free Cash Flow (ttm)442.03k